Who can guess what this deal will be, need money to get rid of Tonaquint loan at 18%.
Might be just a bridge loan then go for more later this year.
Marvtabak, the Turks will likely pay cash to Guided upfront for part of its huge order. Co. didn't disclose dollar terms but it's over $2M, and 2015 guidance is $3M, so they should beat that. Market cap is tiny, so financing won't hurt too much and is already factored into stock price (discounted). Think beyond next week and you'll be bullish as I am. The patents alone are worth at least $25M, and the co. has options. Luviva is a valuable asset worth more cash than the company's current market cap. OTC stock, top secret company, few Americans have ever heard of it and its technology. Gene took over less than 18 months ago, all that hard work is beginning to bear fruit, it took longer than expected but the prize is near now. Buy the dips.
per FDA protocols, and presented detailed results of 55 patients in London in March, 2014, 100% efficacy. In attendance were reps from 37 colposcopy societies. I think that is as at least as good as Mass General. In some nations Luviva was compared to the gold standard biopsy and Luviva has never been rejected in any customer evaulations, per a teleconference answer. I don't know exactly why FDA didn't approve it but Gene answered all the questions in the related call. I didn't jot them down. Yahoo threads are buggy, hate 'em, let's use investor village, far superior coding, no censors. Links, images, vids, etc.
Marv, Turkey will pay some of it upfront to help finance building devices which begin shipping in Oct., 2015. Co. will get a bridge loan to carry them thru til they can finance operations from sales.
Big order from Kenya is expected someday, part of it should come this month or early July, per CEO Gene in the teleconference.
Sales should exceed $3m 2015 guidance, many buyers have completed evaluations now, waiting on red tape from govts., Ministries of Health.
China/Hong Kong in the pipe now, too, with approval in H. K. less than a year, China about a year, for medical devices.
It's not a dream, it's a plan. Need that P.O. from Kenya by October. Yes, they can meet criteria, if they execute their plan. Gene has been slow and has been desperate in negotiating financings, he made mistakes, has learned a ton and orders were delayed not canceled. The new warrants and conversion strike prices cannot be repriced under the current contracts so that's what I mean when I say the toxic financings have been cleaned up to a degree. With firm orders in hand - funding is already in place - financing mfg. will be easy and nondilutive. High risk High reward situation, I'm long in decent size but not in a stupid amount. Don't gauge the state of the company by daily stock price fluctuations. I've seen 100s of seemingly dead companies/stocks spring back to life vigorously. This may well be one of them, some patience is required. They are not going under.
dude, getting the money to mfg for orders in hand is the easy part! Financing for ops with no orders is what crushed the stock....business 101 here
That may change thanks to businesses such as OriginClear Inc., a Los Angeles-based licensor of technology that purifies wastewater by zapping it with electric pulses. OriginClear has run pilot projects for both CRC and natural-gas producer Aera Energy LLC, William Charneski, OriginClear’s senior vice president, said in a Dallas interview.
Article is titled:
California Farms Are Using Fracking Wastewater to Grow Crops
link may get eaten here, will try to post it next
He called it a CG co., that's where the big money is. I'm a long term investor trading around a core a little, never forced anyone to buy the stock. It took a long time for him to get to this point, 17 months? See what the next 3 and next 6 months bring.
Everything Gene said privately had already been publicized by him or the company. Gray area but not FD violations. He believed FDA would approve conditionally, I didn't get hung up on exact words, as you recall he said he expected something that you said does not exist, in an informal private email which I posted. He's been pursuing top-down sales for entire nations, that takes much time, effort, and politics gets in the way sometimes, wars, currencies fluctuations, etc. He is doing ok for 17 months on the job with more big fish ready to land in the boat.
Lilith, I am so disappointed! I want at least 10 thumbs down on that TA post. They won't, can't, shouldn't, r/s until/unless the stock is much higher. Stocks go up and down, my plan is to make money on them regardless, trading and speculating.
Lilith, it is very much common knowledge that Docs are change-averse. I've seen countless better products grow sales very slowly simply because Docs hate to change. Based on trial data per FDA protocols, 1607 and 55 by Dr. Bentley, no one can say Luviva isn't the best in the world at what it does.
They await FDA approval. In the meantime, guided is building a market overseas, and only needs $10/year to b/e. If they achieve that, won't need a partner, won't need to sell the co. The distributors are their partners. All this bearishness is great, it means there is only upside if and when they execute.
I think it's pretty simple. Awful, desperate, financings were done because the co. had no better alternatives and they crushed the stock price. The market cap is a different calculation, number of shares out and also the fully diluted number, with an authorization up to 500M coming soon. Slow sales progress led to those financings despite major cost cutting. So now the only way out of the mess is very large profitable sales and soon. Turkey? Check. Kenya? Soon. 2016? Looks promising if one can see beyond the haze of pain.
Who cares about FDA and the small, triage market in the U. S.? Only 5-10% of screened patients would be candidates for Luviva. Guided is pursuing the national markets that have the highest potential for cervical guide usage because that's the profit center. Give this one time, they have a solid foot in the door in China/Hong Kong and rest of Asia will follow. Many years of hard work and frustrations is about to pay off in a large way, this one can easily make 10 times your money by end of 2016. Think forward, do the math, I've studied this one thoroughly, incl. competition, best I am able. They've come this far, no way they'll let it go under. Patents, Luviva, are worth more than today's market cap, fully diluted.
Don't miss the monster turn, Lili, this could be the comeback of dreams, the tech works, the market is there and willing. Past is not prologue.
Hi, Green, why not just join at investor village? These threads drive me batty, can't tell who replies to whom, posts missing, some get deleted, too buggy. The presentations at co. site don't stay there forever but it's still a good source of info. I've studied this one thoroughly since early 2013 and I have a decent memory. The telec. transcripts are now at seekingalpha incl. Q & A. Right now I sense a ton of bearishness, given up hope, and waiting for the bridge financing before stepping in. One day, one step, at a time -- this huge order changed my mind somewhat about this company and its stock. Let's see what they do next, Kenya order is due soon. So many customer evaluations, many purchase orders can hit in a short time and really push the stock higher and make many aware of it. OTC stocks don't get news highlighted at SA, in their great news stream.
Some of my navb pals are at IV gthp, we had a wild ride, I did a ton of trading over the years, they post there about gthp.